RenovoRx (RNXT) Total Current Liabilities (2024 - 2025)

RenovoRx's Total Current Liabilities history spans 2 years, with the latest figure at $1.9 million for Q3 2025.

  • For Q3 2025, Total Current Liabilities rose 6.32% year-over-year to $1.9 million; the TTM value through Sep 2025 reached $1.9 million, up 6.32%, while the annual FY2024 figure was $1.9 million, N/A changed from the prior year.
  • Total Current Liabilities for Q3 2025 was $1.9 million at RenovoRx, up from $1.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.9 million in Q4 2024 and bottomed at $1.1 million in Q1 2024.